The clinical meaningfulness of ADAS-Cog changes in Alzheimer's disease patients treated with donepezil in an open-label trial
-
* Corresponding author: Kenneth Rockwood Kenneth.Rockwood@Dal.ca
BMC Neurology 2007, 7:26 doi:10.1186/1471-2377-7-26
Accesses
- Last 30 days: 275 accesses
- Last 365 days: 3372 accesses
- All time: 14121 accesses